3RB.DE - Reckitt Benckiser Group plc

XETRA - XETRA Delayed price. Currency in EUR
70.32
-0.21 (-0.30%)
At close: 5:35PM CET
Stock chart is not supported by your current browser
Previous close70.53
Open70.86
Bid70.27 x 900
Ask70.36 x 5000
Day's range69.81 - 70.86
52-week range63.92 - 76.03
Volume3,684
Avg. volume7,300
Market cap49.322B
Beta (3Y monthly)0.31
PE ratio (TTM)5.79
EPS (TTM)12.15
Earnings dateN/A
Forward dividend & yield1.65 (2.36%)
Ex-dividend date2019-08-22
1y target estN/A
  • How Does Reckitt Benckiser Group plc (LON:RB.) Fare As A Dividend Stock?
    Simply Wall St.

    How Does Reckitt Benckiser Group plc (LON:RB.) Fare As A Dividend Stock?

    Could Reckitt Benckiser Group plc (LON:RB.) be an attractive dividend share to own for the long haul? Investors are...

  • Britain's Reckitt Benckiser gives new parents more paid leave
    Reuters

    Britain's Reckitt Benckiser gives new parents more paid leave

    Mothers will also have the option to take a further six months of leave without pay. The Durex condom and Lysol disinfectant maker also said it would increase paid paternity leave for fathers and partners to four weeks, with the option to take a further four weeks of leave without pay. Reckitt Benckiser has also launched suites for breastfeeding mothers returning to work and free breast pumps if needed.

  • Reckitt Benckiser gives new parents more paid leave
    Reuters

    Reckitt Benckiser gives new parents more paid leave

    Mothers will also have the option to take a further six months of leave without pay. The Durex condom and Lysol disinfectant maker also said it would increase paid paternity leave for fathers and partners to four weeks, with the option to take a further four weeks of leave without pay. Reckitt Benckiser has also launched suites for breastfeeding mothers returning to work and free breast pumps if needed.

  • The Reckitt Benckiser share price – where next?
    Stockopedia

    The Reckitt Benckiser share price – where next?

    The Reckitt Benckiser (LON:RB.) share price has risen by 4.13% over the past month and it’s currently trading at 6068p. For investors considering whether to bu8230;

  • Reuters - UK Focus

    UPDATE 2-FTSE trips on ex-div trade, U.S.-China trade doubts

    London's FTSE 100 retreated from a near four-month high on Thursday, weighed down by stocks trading ex-dividend and as U.S. ratification of legislation on Hong Kong raised concerns that progress in trade talks with China may be undone. The blue-chip index fell 0.2% after four straight days of gains, with Vodafone giving up nearly 4% and utility National Grid shedding almost 3% as they traded without entitlement to a dividend pay-out.

  • Reuters - UK Focus

    UPDATE 2-Election polls thrust UK midcaps to 14-month high

    UK mid-caps closed at their highest level in nearly 14 months on Monday, boosted by polls pointing to victory by the ruling Conservatives in upcoming elections, while a near 5% drop in insurer Aviva weighed on the main board. The domestically-focused FTSE 250 index rose 0.2% while the FTSE 100 added 0.1%.

  • Insider Buying: The Reckitt Benckiser Group plc (LON:RB.) Chief Operating Officer of Health Just Bought UK£291k Worth Of Shares
    Simply Wall St.

    Insider Buying: The Reckitt Benckiser Group plc (LON:RB.) Chief Operating Officer of Health Just Bought UK£291k Worth Of Shares

    Investors who take an interest in Reckitt Benckiser Group plc (LON:RB.) should definitely note that the Chief...

  • Reuters - UK Focus

    UPDATE 2-New York, states reach $700 mln settlement with Reckitt over opioid probes

    New York and other states have reached a $700 million settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday. The deal is a part of an up to $1.4 billion settlement agreed to in July to resolve U.S. state and federal claims that Reckitt Benckiser's former pharmaceuticals business Indivior, before it was spun out, carried out an illegal scheme to boost sales of opioid addiction treatment Suboxone.

  • Reuters

    New York, states reach $700 million settlement with Reckitt over opioid probes

    The deal is a part of an up to $1.4 billion settlement agreed to in July to resolve U.S. state and federal claims that Reckitt Benckiser's former pharmaceuticals business Indivior, before it was spun out, carried out an illegal scheme to boost sales of opioid addiction treatment Suboxone.

  • Reuters - UK Focus

    LIVE MARKETS-Closing snapshot: Brexit ultimatum

    * European shares up and down in choppy station * Waiting for another crunch Brexit vote * Results in focus: Saab rallies, Reckitt down sharply * M&A heats up in food delivery: Prosus makes rival bid for Just Eat * Wall Street higher Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net CLOSING SNAPSHOT: BREXIT ULTIMATUM (1550 GMT) It is one of those days when it looks like the market is just waiting for the Brexit vote... Again! The pan European index has been moving up and down in positive territory during the afternoon as investors avoid big bets due to Brexit uncertainty.

  • Reuters - UK Focus

    LIVE MARKETS-One less thing to worry about on Q3 Thursday

    * European shares up and down in choppy station * STOXX 600 flat, FTSE 100 up 0.5% * Waiting for another crunch Brexit vote * Results in focus: Saab rallies, Reckitt down sharply * M&A heats up in food delivery: Prosus makes rival bid for Just Eat * Wall Street higher Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net ONE LESS THING TO WORRY ABOUT ON Q3 THURSDAY (1422 GMT) This coming Thursday will be key in setting the tone for the overall Q3 earnings season with a flurry of blue chips reporting profits across geographies and sectors. One comforting thought is that while scrutinising P&Ls for any sign of a bottom-up or a further macro gloom contamination, investors need not, at least it seems, to worry about the colour of Draghi's tie at the ECB press conference.

  • Reuters - UK Focus

    LIVE MARKETS-Brexit: More upside yet for UK midcaps?

    * European shares up and down in choppy station * STOXX 600 flat, FTSE 100 up 0.5% * Results in focus: Saab rallies, Reckitt down sharply * M&A heats up in food delivery: Prosus makes rival bid for Just Eat * Dow futures turn lower after McDonald's Q3 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net BREXIT: MORE UPSIDE YET FOR UK MIDCAPS? Anyhow, here are a few quotes making that point from analysts we just spoke too while refreshing this story from Friday: Brexit nod from parliament to unleash 4% rally in pound, send UK plc to record high Here you go: Evan Brown, Head of Multi-Asset Strategy at UBS AM: "If a deal is passed, which is our base case, then we expect the news to be positive at the margin for all UK equities in a global context.

  • Reuters - UK Focus

    LIVE MARKETS-How's 2019? Actually, it's rarely been better!

    * European shares up in choppy station * STOXX 600 up 0.1%, FTSE 100 up 0.6% * Results in focus: Saab rallies, Reckitt down sharply * M&A heats up in food delivery: Prosus makes rival bid for Just Eat Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. Reach him on Messenger to share your thoughts on market moves: julien.ponthus.thomsonreuters.com@reuters.net HOW'S 2019? ACTUALLY, IT'S RARELY BEEN BETTER! (1003 GMT) With the trade war and Brexit looking less threatening by the day, there doesn't seem to be much in store to spoil 2019 returns for European equities - that is, if Q3 results don't prove disastrous.

  • Reuters - UK Focus

    LIVE MARKETS-Who performs better in times global growth scares?

    * European shares down slightly after positive start * STOXX 600 down 0.1%, FTSE 100 up 0.3% * Results in focus: Saab rallies, Reckitt down sharply * M&A heats up in food delivery: Prosus makes rival bid for Just Eat Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. 1. The rest of the world is more cyclical: the S&P 500 is only 40% exposed to manufacturing compared to 52% and 62% in Japan and Europe 2. In prior episodes of weakened global growth, the US has outperformed relative to the rest of the world (Danilo Masoni) ***** OPENING SNAPSHOT: OVERALL FLAT BUT PLENTY OF Q3 SWINGS (0733 GMT) The STOXX 600 opened just slightly positive but most European indexes are now tilted to the downside.

  • Reuters - UK Focus

    GLOBAL MARKETS-Earnings weigh on European stocks, sterling lower before Brexit votes

    European shares edged lower on Tuesday as talk of progress in China-U.S. trade talks was offset by mixed corporate earnings, while sterling retreated ahead of another vote on Brexit. The broad European STOXX slipped 0.3%, and MSCI's world equity index, which tracks shares in 47 countries, was flat at 0.02% lower.

  • Reuters - UK Focus

    UPDATE 2-European stocks subdued by mixed corporate earnings and Brexit

    Mixed earnings reports kept a lid on European stocks, with London's midcap index suffering from doubts over whether British lawmakers will back the government's Brexit bill on Tuesday. The pan-European STOXX 600 finished up just 0.1%, with a weaker pound helping London's exporter-laden FTSE 100 outperform with a 0.7% gain. The FTSE 100 was also lifted by a 24% jump in food delivery firm Just Eat after Dutch internet conglomerate Prosus made an unsolicited $6.3 billion cash bid.

  • Reuters - UK Focus

    LIVE MARKETS-Opening snapshot: Overall flat but plenty of Q3 swings

    * European shares down slightly after positive start * STOXX 600 down 0.2%, FTSE 100 flat, DAX up 0.1% * Results in focus: Saab rallies, Reckitt down sharply Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. It seems that this is likely to be a choppy session with Q3 results triggering sharp individual moves. The biggest winner is clearly Swedish defence firm Saab which had results well ahead of market forecasts and is up close to 6%.

  • Reuters - UK Focus

    CORRECTED-European shares dip after flood of earnings

    European shares inched lower on Tuesday as investors sifted through a mixed bag of corporate earnings and eyed latest developments on U.S.-China trade talks and Britain's progress towards some form of orderly departure from the European Union. Germany's DAX and Switzerland's SSMI both bucked the trend, with the latter helped by a 1% gain for drugmaker Novartis after it raised its 2019 targets and reported better-than-expected revenue. British household goods maker Reckitt Benckiser was moored to the bottom of the pan-European STOXX index with a 5% fall after it cut its full-year sales forecast for the second time this year.

  • Reuters - UK Focus

    LIVE MARKETS-On the radar: Q3 matters

    Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Julien Ponthus. European bourses are now seen opening sideways with a lot of corporate news to digest. Sunrise Communications Group is expected to rise after it bowed to investor pressure and scrapped a rights issue needed to complete the acquisition of Liberty Global's UPC business.

  • Reuters - UK Focus

    RPT-UPDATE 3-New CEO vows improvements as Reckitt cuts sales forecast again

    Reckitt Benckiser's new chief executive promised on Tuesday to step up spending on its brands and improve performance after the British household goods maker cut its full-year sales forecast for a second time. "We are not pleased with where we are and we must consistently deliver," Laxman Narasimhan, who took over from long-time CEO Rakesh Kapoor in September, said on his first call with the investment community. Narasimhan particularly lamented the performance of the firm's Health business, its largest, where a failed product launch, the nearly $17 billion acquisition of Mead Johnson, and a temporary baby milk factory shutdown in the Netherlands, have all caused significant disruption, some lasting to this day.

  • New CEO vows improvements as Reckitt cuts sales forecast again
    Reuters

    New CEO vows improvements as Reckitt cuts sales forecast again

    Reckitt Benckiser's new chief executive promised on Tuesday to step up spending on its brands and improve performance after the British household goods maker cut its full-year sales forecast for a second time. "We are not pleased with where we are and we must consistently deliver," Laxman Narasimhan, who took over from long-time CEO Rakesh Kapoor in September, said on his first call with the investment community. Narasimhan particularly lamented the performance of the firm's Health business, its largest, where a failed product launch, the nearly $17 billion acquisition of Mead Johnson, and a temporary baby milk factory shutdown in the Netherlands, have all caused significant disruption, some lasting to this day.

  • Reuters - UK Focus

    UPDATE 2-Reckitt hires Ahold's Carr to take over as CFO in 2020

    Reckitt Benckiser named Ahold Delhaize finance chief Jeff Carr as successor to Adrian Hennah, who is retiring as CFO of the British consumer goods company next year. The maker of Durex condoms and Lysol disinfectant said on Monday that Carr, who has been finance chief at Dutch-American supermarket operator Ahold since 2011, would bring "extensive experience across consumer and retail companies". The appointment of Carr, who worked for Reckitt between 1994 and 2004, is its second big management change this year after replacing long-time chief executive Rakesh Kapoor with PepsiCo executive Laxman Narasimhan as CEO.

  • Reckitt hires Ahold's Carr to take over as CFO in 2020
    Reuters

    Reckitt hires Ahold's Carr to take over as CFO in 2020

    The maker of Durex condoms and Lysol disinfectant said on Monday that Carr, who has been finance chief at Dutch-American supermarket operator Ahold since 2011, would bring "extensive experience across consumer and retail companies". The appointment of Carr, who worked for Reckitt between 1994 and 2004, is its second big management change this year after replacing long-time chief executive Rakesh Kapoor with PepsiCo executive Laxman Narasimhan as CEO.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more